Revolution Medicines, Inc., a clinical-stage precision oncology company, develops novel targeted therapies for RAS-addicted cancers. The company's research and development pipeline includes RAS(ON) inhibitors designed to be used as monotherapy in combination with other RAS(ON) inhibitors and/or in combination with RAS companion inhibitors or other therapeutic agents, and RAS companion inhibitors for combination treatment strategies. Its RAS(ON) inhibitors include daraxonrasib (RMC-6236), elironrasib G12C (RMC-6291), and zoldonrasib G12D (RMC-9805), which are in phase 1 clinical trial; and development candidates comprise RMC-5127 (G12V), RMC-0708 (Q61H), and RMC-8839 (G13C). The company's RAS companion inhibitors include RMC-4630 that is in phase 2 clinical trial; and RMC-5552, which is in phase 1 clinical trial. Revolution Medicines, Inc. was incorporated in 2014 and is headquartered in Redwood City, California.

Revolution Medicines Inc - Ordinary Shares

In a report released today, Laura Prendergast from Stifel Nicolaus maintained a Buy rating on Revolution Medicines, with a price target of $215.00....

Stifel Nicolaus Sticks to Their Buy Rating for Revolution Medicines (RVMD)

Oppenheimer analyst Jay Olson maintained a Buy rating on Revolution Medicines today and set a price target of $195.00. According to TipRanks, Olson...

Oppenheimer Remains a Buy on Revolution Medicines (RVMD)

Analysts have been eager to weigh in on the Healthcare sector with new ratings on CVS Health (CVS), Revolution Medicines (RVMD) and Neumora Therape...

Market Cap	$11.79B	P/E Ratio	N/A
52W High	$166.50	52W Low	$34.00
Div Yield	N/A	Payout Ratio	N/A
EPS Growth 3Y	-24.5%	52W Position	97.4%
Overall Score	57	Value Score	40
Quality Score	42	Technical Score	91

EPS Current Est	$-7.94	EPS Next Est	$-5.32
EPS Growth Est	N/A	DPS Growth 3Y	N/A

	A	B	C	D
1	Symbol	Price	Change	Volume
2	RVMD	$162.99	+3.31%	4.70M
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	RVMD	$162.99	+3.3%	4.70M
3
4
5
6

RVMD

RVMD

Key Metrics Overview

Growth Analysis

Revenue (5Y)

EBITDA (5Y)

Get Revolution Medicines Inc - Ordinary Shares Data in Excel

Get Revolution Medicines Inc - Ordinary Shares Data in Excel